Munich, February 8, 2023   Disclosure of an inside information according to Article 17 MAR   Siemens raises outlook for fiscal year 2023   Following a strong start in fiscal 2023, the Managing Board of Siemens AG decided today to raise the outlook for fiscal 2023 as follows:   For the Siemens Group Siemens now expects comparable revenue gr [ … ]

Munich, February 8, 2023   Disclosure of an inside information according to Article 17 MAR   Siemens raises outlook for fiscal year 2023   Following a strong start in fiscal 2023, the Managing Board of Siemens AG decided today to raise the outlook for fiscal 2023 as follows:   For the Siemens Group Siemens now expects comparable revenue gr [ … ]

Munich, June 30, 2022 Disclosure of an inside information according to Article 17 MAR   Siemens announces impairment of an at‐equity investment With Siemens Energy AG's Xetra closing share price of €13.99 on June 30, 2022, the market value of Siemens’ 35% investment in Siemens Energy AG (SE) is significantly below the book value. This leads to [ … ]

Munich, June 30, 2022 Disclosure of an inside information according to Article 17 MAR   Siemens announces impairment of an at‐equity investment With Siemens Energy AG's Xetra closing share price of €13.99 on June 30, 2022, the market value of Siemens’ 35% investment in Siemens Energy AG (SE) is significantly below the book value. This leads to [ … ]

Munich, January 21, 2021 Disclosure of an inside information according to Article 17 MAR Preliminary operating results for first quarter of fiscal year 2021 significantly above market expectations Following a significantly better-than-expected business performance, the preliminary operating results for Siemens' businesses for the first quarter  [ … ]

Munich, August 2, 2020 Disclosure of an inside information according to Article 17 MAR Siemens welcomes acquisition of Varian by Siemens Healthineers Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG's acquisition of a 100 percent stake in Varian Medical Systems, Inc [ … ]